PMPaula Moreno

Paula Moreno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paula Moreno has a total of 199 co-authors. Here are the top co-authors by number of shared publications:

  • F. Cerezo

    Thoracic Surgery and Lung Transplantation Unit, Reina Sofia University Hospital, Cordoba, Spain

    11 shared publications
  • A. Salvatierra

    Thoracic Surgery and Lung Transplantation Unit, Reina Sofia University Hospital, Cordoba, Spain

    10 shared publications
  • Antonio Alvarez

    Thoracic Surgery and Lung Transplantation Unit, University Hospital Reina Sofía, Córdoba, Spain

    10 shared publications
  • C. Baamonde

    Thoracic Surgery and Lung Transplantation Unit, University Hospital Reina Sofía, Córdoba, Spain

    10 shared publications
  • Carlos Baamonde

    Thoracic Surgery and Lung Transplantation Department, University Hospital Reina Sofia, Cordoba, Spain

    8 shared publications
  • Angel Salvatierra

    Thoracic Surgery and Lung Transplantation Department, University Hospital Reina Sofia, Cordoba, Spain

    7 shared publications

Latest Publications

  • Open Access

    Deep representation learning of tissue metabolome and computed tomography annotates NSCLC classification and prognosis

    by Marc Boubnovski Martell, Kristofer Linton-Reid, Sumeet Hindocha, Mitchell Chen, Paula Moreno, Marina Álvarez‐Benito, Ángel Salvatierra, Richard Lee, Joram M. Posma, Marco A. Calzado, et al.

    The rich chemical information from tissue metabolomics provides a powerful means to elaborate tissue physiology or tumor characteristics at cellular and tumor microenvironment levels. However, the process of obtaining such information requires invasive biopsies, is costly, and can delay clinical patient management. Conversely, computed tomography (CT) is a clinical standard of care but does not intuitively harbor histological or prognostic information. Furthermore, the ability to embed metabolome information into CT to subsequently use the learned representation for classification or prognosis has yet to be described. This study develops a deep learning-based framework -- tissue-metabolomic-radiomic-CT (TMR-CT) by combining 48 paired CT images and tumor/normal tissue metabolite intensities to generate ten image embeddings to infer metabolite-derived representation from CT alone. In clinical NSCLC settings, we ascertain whether TMR-CT results in an enhanced feature generation model solving histology classification/prognosis tasks in an unseen international CT dataset of 742 patients. TMR-CT non-invasively determines histological classes - adenocarcinoma/squamous cell carcinoma with an F1-score = 0.78 and further asserts patients’ prognosis with a c-index = 0.72, surpassing the performance of radiomics models and deep learning on single modality CT feature extraction. Additionally, our work shows the potential to generate informative biology-inspired CT-led features to explore connections between hard-to-obtain tissue metabolic profiles and routine lesion-derived image data.


  • Open Access

    Influence of De Novo Malignancies on Long-Term Survival after Lung Transplantation

    by Eloisa Ruiz, Paula Moreno, Francisco Javier Gonzalez, Alba Maria Fernandez, Benito Cantador, Juan Luis Parraga, Angel Salvatierra, Antonio Alvarez

    (1) Background: Malignancies are an important cause of mortality after solid organ transplantation. The purpose of this study was to analyze the incidence of malignancies in patients receiving lung transplants (LT) and their influence on patients’ survival. (2) Methods: Review of consecutive LT from 1994 to 2021. Patients with and without malignancies were compared by univariable and multivariable analyses. Survival was compared with Kaplan-Meier and Cox regression analysis. (3) Results: There were 731 LT malignancies developed in 91 patients (12.4%) with related mortality of 47% (n = 43). Native lung cancer, digestive and hematological malignancies were associated with higher lethality. Malignancies were more frequent in males (81%; p = 0.005), transplanted for emphysema (55%; p = 0.003), with cyclosporine-based immunosuppression (58%; p < 0.001), and receiving single LT (65%; p = 0.011). Survival was worse in patients with malignancies (overall) and with native lung cancer. Risk factors for mortality were cyclosporine-based immunosuppression (OR 1.8; 95%CI: 1.3–2.4; p < 0.001) and de novo lung cancer (OR 2.6; 95%CI: 1.5–4.4; p < 0.001). (4) Conclusions: Malignancies are an important source of morbidity and mortality following lung transplantation that should not be neglected. Patients undergoing single LT for emphysema are especially at higher risk of mortality due to lung cancer in the native lung.


  • Open Access

    Deep Representation Learning of Tissue Metabolome and Computed Tomography Images Annotates Non-invasive Classification and Prognosis Prediction of NSCLC

    by Marc Boubnovski Martell, Kristofer Linton-Reid, Sumeet Hindocha, Mitchell Chen, Octapus- Ai, Paula Moreno, Marina Álvarez-Benito, Ángel Salvatierra, Richard Lee, Joram M. Posma, et al.

    The rich chemical information from tissue metabolomics provides a powerful means to elaborate tissue physiology or tumor characteristics at cellular and tumor microenvironment levels. However, the process of obtaining such information requires invasive biopsies, is costly, and can delay clinical patient management. Conversely, computed tomography (CT) is a clinical standard of care but does not intuitively harbor histological or prognostic information. Furthermore, the ability to embed metabolome information into CT to subsequently use the learned representation for classification or prognosis has yet to be described. This study develops a deep learning-based framework -- tissue-metabolomic-radiomic-CT (TMR-CT) by combining 48 paired CT images and tumor/normal tissue metabolite intensities to generate ten image embeddings to infer metabolite-derived representation from CT alone. In clinical NSCLC settings, we ascertain whether TMR-CT achieves state-of-the-art results in solving histology classification/prognosis tasks in an unseen international CT dataset of 742 patients. TMR-CT non-invasively determines histological classes - adenocarcinoma/ squamous cell carcinoma with an F1-score=0.78 and further asserts patients' prognosis with a c-index=0.72, surpassing the performance of radiomics models and clinical features. Additionally, our work shows the potential to generate informative biology-inspired CT-led features to explore connections between hard-to-obtain tissue metabolic profiles and routine lesion-derived image data.

  • Open Access

    Airway Complications after Lung Transplantation—A Contemporary Series of 400 Bronchial Anastomoses from a Single Center

    by Anna Muñoz-Fos, Paula Moreno, Francisco Javier González, Eloisa Ruiz, Jose Manuel Vaquero, Carlos Baamonde, Francisco Cerezo, Javier Algar, Ricard Ramos-Izquierdo, Ángel Salvatierra, et al.

    (1) Objective: To determine whether recent advances in lung transplantation (LT) have reduced the incidence and changed the risk factors for airway complications (AC). (2) Methods: Retrospective analysis of patients receiving a lung transplant between January 2007 and January 2019. An AC was defined as a bronchoscopic abnormality in the airway, either requiring or not requiring an endoscopic or surgical intervention. Both univariable and multivariable analyses were performed to identify risk factors for AC. (3) Results: 285 lung transplants (170 single and 115 bilateral lung transplants) were analysed, comprising 400 anastomoses at risk. A total of 50 anastomoses resulted in AC (12%). There were 14 anastomotic and 11 non-anastomotic stenoses, 4 dehiscences, and 3 malacias. Independent predictors for AC were: gender male (OR: 4.18; p = 0.002), cardiac comorbidities (OR: 2.74; p = 0.009), prolonged postoperative mechanical ventilation (OR: 2.5; p = 0.02), PaO2/FiO2 < 300 mmHg at 24 h post-LT (OR: 2.48; p = 0.01), graft infection (OR: 2.16; p = 0.05), and post-LT isolation of Aspergillus spp. (OR: 2.63; p = 0.03). (4) Conclusions: In spite of advances in lung transplantation practice, the risk factors, incidence, and lethality of AC after LT remains unchanged. Graft dysfunction, an infected environment, and the need of prolonged mechanical ventilation remain an Achilles heel for AC.


  • Living-donor lobar lung transplantation: a powerful but still undervalued resource to overcome donor shortage

    by Paula Moreno, Antonio Alvarez

    Paula Moreno, Antonio Álvarez; Living-Donor Lobar Lung Transplantation: A Powerful BUT Still Undervalued Resource To Overcome Donor Shortage, European Journal o


  • Spanish Society of Thoracic Surgery (SECT) consensus document. Long-term follow-up for operated patients with lung cancer

    by Ángel Cilleruelo Ramos, Santiago Figueroa Almánzar, Rafael López Castro, Néstor J. Martínez Hernández, Laura Mezquita Pérez, Paula Moreno Casado, Jon Zabaleta Jiménez


  • Open Access

    Survival After Lung Transplantation for Chronic Hypersensitivity Pneumonitis: Results From a Large International Cohort Study

    by Mario Nosotti, Mario Nosotti, Miguel Leiva-Juarez, Miguel Leiva-Juarez, Frank D’oVidio, Frank D’oVidio, Dirk Van Raemdonck, Dirk Van Raemdonck, Laurens Ceulemans, Laurens Ceulemans, et al.

    Repeated exposure to antigens via inhalation is the primary cause of hypersensitivity pneumonitis, a form of interstitial pneumonia. The chronic form of hypersensitivity pneumonitis leads to progressive loss of respiratory function; lung transplantation is the only therapeutic option for chronically ill patients. The ESTS Lung Transplantation Working Group conducted a retrospective multicentred cohort study to increase the body of knowledge available on this rare indication for lung transplantation. Data were collected for every patient who underwent lung transplant for hypersensitivity pneumonitis in participating centres between December 1996 and October 2019. Primary outcome was overall survival; secondary outcome was freedom from chronic lung allograft dysfunction. A total of 114 patients were enrolled from 9 centres. Almost 90% of patients were diagnosed with hypersensitivity pneumonitis before transplantation, yet the antigen responsible for the infection was identified in only 25% of cases. Eighty per cent of the recipients received induction therapy. Survival at 1, 3, and 5 years was 85%, 75%, and 70%, respectively. 85% of the patients who survived 90 days after transplantation were free from chronic lung allograft dysfunction after 3 years. The given study presents a large cohort of HP patients who underwent lung transplants. Overall survival rate is higher in transplanted hypersensitivity pneumonitis patients than in those suffering from any other interstitial lung diseases. Hypersensitivity pneumonitis patients are good candidates for lung transplantation.


  • Lung Transplantation in a Young Patient With Pulmonary Artery Hypertension After Arterial Switch Operation: A Case Report

    by David Poveda, Eloisa Ruiz, Alba Maria Fernandez, Francisco Javier Gonzalez, Paula Moreno, Francisco Javier Algar, Francisco Cerezo, Carlos Baamonde, Angel Salvatierra, Antonio Alvarez


  • Open Access

    Relationship Among Radiological Measurements of Anterior Mediastinal Fat and Outcomes of Lung Transplantation in Fibrotic Patients

    by Francisco Javier González, Antonio Alvarez, Benito Cantador, Paula Moreno, Carlos Baamonde, Anna Muñoz, David Poveda, Francisco Javier Algar, Francisco Cerezo, Angel Salvatierra


  • Open Access

    LUBAC determines chemotherapy resistance in squamous cell lung cancer

    by E. Josue Ruiz, Markus E. Diefenbacher, Jessica K. Nelson, Rocio Sancho, Fabio Pucci, Atanu Chakraborty, Paula Moreno, Alessandro Annibaldi, Gianmaria Liccardi, Vesela Encheva, et al.

    Lung squamous cell carcinoma (LSCC) and adenocarcinoma (LADC) are the most common lung cancer subtypes. Molecular targeted treatments have improved LADC patient survival but are largely ineffective in LSCC. The tumor suppressor FBW7 is commonly mutated or down-regulated in human LSCC, and oncogenic KRasG12D activation combined with Fbxw7 inactivation in mice (KF model) caused both LSCC and LADC. Lineage-tracing experiments showed that CC10+, but not basal, cells are the cells of origin of LSCC in KF mice. KF LSCC tumors recapitulated human LSCC resistance to cisplatin-based chemotherapy, and we identified LUBAC-mediated NF-κB signaling as a determinant of chemotherapy resistance in human and mouse. Inhibition of NF-κB activation using TAK1 or LUBAC inhibitors resensitized LSCC tumors to cisplatin, suggesting a future avenue for LSCC patient treatment.